New York, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and ...

Viruses have evolved by borrowing and modifying cellular genes to become extremely efficient at nucleic acid delivery to different cell types, avoiding at the same time immunosurveillance by an ...

A synthetic viral vector and a novel surgical approach developed at Mass Eye and Ear has enabled efficient gene transfer into the inner ear of nonhuman primates, a research team working towards the ...

EMERYVILLE, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full ...

CHICAGO--(BUSINESS WIRE)--Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to ...

The lentiviral vector is a promising tool for human gene therapy because of its ability to transduce genes into many cell types. However, one of the technical problems associated with the lentiviral ...

Step into any laboratory that works with DNA, such as one creating genetic medicines, and there’s a good chance that you’ll find flasks filled with bacterial broths swirling away in oven-like ...